tm logo

Monitor this mark

View On USPTO

AMNUVX
Live/Pending
FIRST EXTENSION - GRANTED

granted

on 12 Sep 2024

Last Applicant/ Owned by

Organogenesis Inc.

85 Dan Road

Canton

MA

02021

Serial Number

98024793 filed on 02th Jun 2023

Registration Number

N/A

Correspondent Address

Joshua S. Jarvis, Esq.

Joshua S. Jarvis, Esq. FOLEY HOAG LLP

BOSTON, MA 02210

United States

Filing Basis

1. intent to use

2. intent to use current

Disclaimer

NO DATA

AMNUVX

Medical preparation containing human biological material, namely, bioactive suspension derived from human amnion and amniotic fluid used in treating degenerative disease of the articulating joints

Classification Information

Class [005]
Pharmaceutical Products

Medical preparation containing human biological material, namely, bioactive suspension derived from human amnion and amniotic fluid used in treating degenerative disease of the articulating joints

First Use Date in General

N/A

First Use Date in Commerce

N/A

Mark Details

Serial Number

No 98024793

Mark Type

No Service/Collective Mark

Attorney Docket Number

No 21581.00091

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History

Show more

Status DateAction Taken
12th Sep 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
12th Sep 2024SOU EXTENSION 1 GRANTED
12th Sep 2024SOU EXTENSION 1 FILED
12th Sep 2024SOU TEAS EXTENSION RECEIVED
21st May 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
26th Mar 2024PUBLISHED FOR OPPOSITION
26th Mar 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
06th Mar 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
06th Mar 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
20th Feb 2024APPROVED FOR PUB - PRINCIPAL REGISTER